Algo version: 0.98b
Biotage AB (publ) is listed at the STO Exchange
Biotage AB (publ) [BIOT.ST]
STO Sector: Healthcare Industry:Medical Instruments & Supplies

Is Biotage AB (publ) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Biotage AB (publ) pays dividends. Last time was Friday 3rd of May 2024 where the investors holding the stock on Friday 26th of April 2024 were paid SEK1.6 per share. Over the last 15 times between 2009 and 2024, Biotage AB (publ) has paid SEK13.55 with an average of SEK0.9 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Biotage AB (publ) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SEK99.20, you would have made a profit of SEK88.60 per share or 89.31%

Yes, the average daily trading liquidity for Biotage AB (publ) is SEK84 196 thousand. You should therefore be able to get in and out of your positions relatively fast.

Biotage AB (publ) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.71, the company's ability to pay off the debt is good. Biotage AB (publ) has a good net profit margin of 11.91% and should have high tolerances against inflation.

We have calculated the inflation risk for Biotage AB (publ) to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.